Marie-virginie V. Larcher
Pierre-la-treiche, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Eosinophils gone missing: The analyser mix-up mystery.
Journal: British journal of haematology
Published: January 13, 2025
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.
Journal: Cell death discovery
Published: March 08, 2024
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: October 31, 2023
Sickle cell disease and acute leukemia: one case report and an extensive review.
Journal: Annals of hematology
Published: March 20, 2023
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study.
Journal: Transplantation and cellular therapy
Published: July 05, 2022
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Journal: Frontiers in immunology
Published: December 22, 2021
Evaluation of type-B RR dimerization in poplar: A mechanism to preserve signaling specificity?
Journal: Plant science : an international journal of experimental plant biology
Published: July 07, 2021
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
Journal: Leukemia research
Published: June 09, 2021
Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: February 18, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
Journal: Nature communications
Published: September 25, 2020
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study.
Journal: Mediterranean journal of hematology and infectious diseases
Published: January 06, 2020
Last Updated: 09/26/2026